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Abstract: Despite growing research efforts on the preparation of 
(bio)functional liposomes, synthetic capsules cannot reach the 
densities of protein loading and the control over peptide display that 
is achieved by natural vesicles. Here we present a microbial platform 
for high yield production of lipidic nanovesicles, with clickable thiol 
moieties in their outer corona. These nanovesicles show low size 
dispersity, are decorated with a dense, perfectly oriented and 
customizable corona of transmembrane polypeptides. In addition, 
this approach enables encapsulation of soluble proteins into the 
nanovesicles. Due to the mild preparation and loading conditions 
(absence of organic solvents, pH gradients or detergents) and their 
straightforward surface functionalization taking advantage of the 
diversity of commercially-available maleimide derivatives, 
engineering bacterial-based proteoliposomes are an attractive eco-
friendly alternative that can outperform current liposome preparation 
methods. 
Microbial biosynthesis offers significant advantages when in 
glassware synthesis is cost-intensive and/or provides poor yield 
and is particularly relevant for the preparation of fragile 
biomolecules.[1] Nowadays it is no longer limited to small 
molecules. With a growing demand for renewable sources and 
sustainable industrial processes, bioproduction can be an eco-
friendly response for the preparation more advanced materials, 
such as polymers,[2] metal oxide nanoparticles[3,4] and 
supramolecular assemblies of proteins.[5,6] 
To our knowledge, bioproduction has hardly been considered as 
an alternative to in glassware synthesis for lipidic nanovesicles, 
though membranes and compartments are ubiquitous in cells. 
This contrasts with the variety of applications of synthetic 
liposomes, used as encapsulation systems in consumer 
products[7] and nano-medicine to protect fragile active 
compounds.[8] Synthetic liposomes are advantageously 
displaying a variety of molecules on their outer coronae, 
including polymers, peptides, fluorophores, etc, which is key to 
achieve optimal shelf-life, targeting, imaging functions. 
Accordingly, post-modifications in the corona of biological 
proteoliposomes (by conjugation with functional groups) is 
needed to approach the state of art of artificial lipid capsules. A 
recent renewal in this field came from nanovesicles secreted by 
cells in various physiological and pathological conditions.[9] Such 
extracellular vesicles hold promises on innovative therapies and 
diagnostics, but their recovery from cell extracts and batch-to-
batch reproducibility are poor.[10,11] The interest for extracellular 
vesicles is an additional motivation for a versatile bioproduction 
of proteoliposomes. To obtain artificial proteoliposomes and/or 
mimics of membrane cells, the common (in vitro) route is to 
reconstitute purified membrane proteins into liposomes form 
detergent solutions.[12,13] The quality of insertion of membrane 
proteins (native folding and control over in/out orientation) and 
protein densities are however far from approaching the natural, 
cell-secreted vesicles.[11] Due their easy manipulation, bacteria 
provide the most affordable and handy source for nanovesicle 
bioproduction.[14] Diverting the lipid synthesis and protein 
insertion cellular machineries may unlock the access towards 
more controlled proteoliposomes, providing a versatile, eco-
friendly source of functional lipid:protein capsules. 
We present here a platform for the production of bacterial-
sourced proteoliposomes. We obtained well-defined, protein-
loaded nanovesicles displaying a high density surface clickable 
groups (thiols from cysteine-containing tags). At variance with 
previously described approaches, it does not rely on outer 
membrane vesicle secretion suffering from low rate of 
vesiculation.[15] In contrast, we triggered the proliferation of 
internal membranes to increase the vesicle yield,[16,17] producing 
at the same time a dense array of engineered proteins on the 
nanovesicle surface. Internal membrane proliferation was 
achieved by overproducing a engineered membrane protein 
derived from AtpF, the b subunit of F0F1 ATP synthase (ATP-b), 
in C43(DE3) Ecoli strain. This strain specifically evolved and 
trained to produce and fold ATP-b at high levels.[17,18] Up to now, 
they were never considered as a tool to prepare and 
functionalize proteoliposomes. To this aim, we constructed a 
chimeric membrane protein, derived from AtpF, the b subunit of 
F0F1 ATP synthase (ATP-b).
[17] We characterized the 
composition, lipid:protein ratio and explored the surface 
functionalization (via thiol-maleimide click chemistry) of the 
bioproduced vesicles (Figure 1). 
Nanovesicle production, isolation and composition analysis 
The membrane proliferation induced by ATP-b overproduction in 
C43 (DE3) E.coli strain was the chassis for the preparation of 
lipidic nanovesicles containing custom polypeptides (Figure 1a). 
Overproduction of the unmodified wild type ATP-b was 
compared to ATP-b functionalized with a FlAsH tag and a 
Tobacco Etch Virus protease (TEV) digestion sequences 
(quoted ATP-b/F/T) both inserted at position 35,[17] immediately 
after the membrane interaction domain (Figure 1c and Figure S1 
in Supporting Info. N.B.: Attempts to produce ATP-b C-ter and 
N-ter fusion proteins failed to induce membrane proliferation and 
conduced to protein inclusion bodies).[19] FlAsH tag enables in 
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situ specific fluorescence labeling,[20] allowing to identify and 
characterize the recombinant protein (Figure 1b). Additionally, its 
tetra-cysteine motif offers a mean for in vitro post-modifications 
via thiol-maleimide click chemistry. 
 
Figure 1. a) Schematic representation of the preparation of lipid:protein 
nanovesicles b) SDS-PAGE analysis of isolated vesicles and c) cartoon of 
ATP-b and ATP-b/F/T recombinant proteins. FlAsH tag contain four clickable 
thiol sites and TEV digestion site enables for post-cleavage of ATP-b cytosolic 
domain. 
Production yield and qualitative compositions of lipid:protein 
membranes were determined on isolated vesicles obtained after 
bacterial lysis and differential centrifugation(Figure S2). Applying 
this straightforward and fully scalable procedure, we typically 
obtained 50 mg of proteins and 10 mg of lipids per liter of culture 
(Table S1). These amounts well above the yield of outer 
membrane vesicles production, which is generally around 0.5 
mg of vesicles per liter of culture containing c.a. 100 µg of 
proteins.[21,22] Determination of lipid composition of purified 
membranes indicated a mixture of phosphatidylglycerol, 
cardiolipin and phosphatidylethanolamine in molar percentages 
of 18%, 12% and 70% respectively. Purified nanovesicles 
exhibited an unexpectedly low lipid:protein ratio (ca. 0.2 wt/wt), 
showing that the overproduced proteins are densely packed in 
the membranes. For comparison, common formulation methods 
of membrane protein reconstitution into artificial liposomes work 
in a large excess of lipids, at lipid:protein ratios of about 10 to 
800 wt/wt and require the use of detergents.[23] The present in 
vivo bacterial bioproduction system achieves higher protein 
density than any reported method with no need for detergent, 
neither organic solvents that may denature proteins. 
The isolated vesicles contained predominantly the overproduced 
ATP-b scaffold (Figure 1b). The bands of ATP-b (17 kDa) and 
ATP-b/F/T (20 kDa) were identified in SDS-PAGE by both 
Western Blot anti His tag and FlAsH tag in gel fluorescence 
(Figure 1b, using FlAsH-EDT2 pro-fluorophore). In overloaded 
gels, Coomasie blue staining showed two additional major 
protein bands (Figure 1b). They were identified as OmpA (37 
kDa) and OmpF (39 kDa) by MS. The three major protein 
components (ATP-b scaffold, OmpA and OmpF) were 
individually quantified using the fluorescence of tryptophan 
(Table S2).[24] Target peptides (ATP-b and ATP-b/F/T) represent 
ca. 20% wt/wt., whereas the sum of OmpA and OmpF accounts 
for ca. 40% wt/wt. of all proteins. Of note, this weight percentage 
corresponds to a clearly dominant molar fraction of the ATP-b 
peptide because of its low molecular weight (Mw of ATP-b is 
about a tenth of OmpA and OmpF ones). Based on an estimate 
of total mass of all proteins (determined by bicinchoninic acid 
assay), the sum of other proteins (each one being present in 
trace amount, see Figure 1b overloaded lanes) can be estimated 
to account for 40% wt/wt. The presence of OmpA and OmpF 
(major outer membrane proteins forming water-filled unspecific 
pores) in cytosolic membranes is not fully understood. It cannot 
be excluded that membrane proliferation may have facilitated 
unusual insertion of Omp or that contamination occurred during 
cell disruption, a point that will deserve future optimizations. 
The orientation of the overproduced polypeptides in the lipidic 
bilayer was evaluated by assessing the accessibility of ATP-b C-
terminal soluble domain to water soluble proteases.[17,25] As 
trypsin do not spontaneously cross lipid bilayers, the solution-
accessible domains (outer corona of proteoliposomes) are 
degraded much faster than inner components. Both ATP-b and 
ATP-b/F/T were significantly degraded after 12h of incubation at 
30 °C in the presence of trypsin (< 5% of initial intensity remains) 
(Figure 2). When the proteoliposomes were solubilized by 
addition of a surfactant, further progression of trypsinolysis was 
observed (complete degradation of ATP-b, ATP-b/F/T, OmpA 
and of proteins from 40 to 100 kDa, see Figure S4 in SI). 
Regular progression of the proteolysis was observed in a time-
course experiment (Figure S5 in SI). ATP-b/F/T were also 
treated with TEV protease. Specific cleavage of ATP-b/F/T 
soluble domain occurred at the expected position, generating a 
small polypeptide, which retained the fluorescence intensity of 
FlAsH (Figure 2). These results indicate that both the tags and 
cytosolic domain of ATP-b and ATP-b/F/T point towards the 
exterior of the nanovesicles. It should be noted that this almost 
100% oriented display of custom, clickable polypeptides is 
hardly achieved in artificial formulation of liposomes. 
 
Figure 2. In vesicle enzymatic digestion of ATP-b and ATP-b/F/T using non-
specific (trypsin) or sequence specific (TEV) proteases.  
 
Size distribution and thiol-Michael conjugation of the 
nanovesicles 
 
The size and dispersity of vesicles were first measured by DLS 
to explore the impact of mechanical shear used during cell lysis 
(Figure S3 in SI). Increasing the extrusion pressure (from 0.25 to 
2 kBar) gradually decreased the vesicle mean diameter from 
~200 nm to 125 nm. Polydispersity index (PDI) was also slightly 
decreased by application of higher pressures. 2.0 kBar was 
selected as optimal lysis pressure to obtain vesicles with the 
narrowest possible size distribution (Table S3). Under these 
conditions, the diameter of nanovesicles ranged from 100 to 125 
nm and PDI was < 0.2. This size dispersity is similar to what is 
typically achieved by a few extrusion cycles of artificially 
formulated liposomes (PDI of about 0.25 compared to 0.18 in 
our case).[26] Negative staining TEM images show circular 
objects in both ATP-b and ATP-b/F/T samples, confirming the 
presence of lipidic nanovesicles (Figure S6 in SI). 
Figure 3. Size and fluorescence intensity distribution of ATP-b/F/T 
nanovesicles a) nonspecific lipid bilayer spDiO staining and b) Alexa-647 
selective staining of ATP-b/F/T peptide. c) Fluorescence microscopy image of 
nanovesicles stained with spDiO (green), Alexa-647 (red) and merged images 
(yellow). 
Next, the population of nanovesicles was characterized by single 
particle counting using Nanoparticle Tracking Analysis (NTA) 
and the microfluidic device described by Friedrich et al.[27] The 
lipidic bilayer was nonspecifically marked using the lipophilic 
green fluorescent dye spDiO whereas the ATP-b peptide was 
stained with Alexa-647, emitting at near infrared to avoid 
channel cross-talk. Alexa-647 was selectively conjugated to 
ATP-b/F/T FlAsH moieties using thiol-maleimide click chemistry 
(Figure S7). A single and slightly shifted band compared to 
unstained sample was observed in SDS-PAGE gels for ATP-
b/F/T after conjugation (Figure S8). These results suggest that i) 
the coupling reaction can be detected and ii) the vesicles could 
be selectively marked on ATP-b/F/T polypeptides. The 
fluorescence distribution curves (Figure 3a-b) allow to compare 
protein and lipids distributions in the vesicle population. 
Similarity between NTA and spDiO fluorescence intensity 
distributions (Figure 3a) suggests that the nonspecific spDiO dye 
is evenly distributed among the nanovesicle population and is a 
fair reporter of the lipid surface. The agreement between size-
distributions measured by DLS and NTA reinforces this 
statement (Figure S9). ATP-b/F/T fluorescence was 
homogeneously distributed among the nanovesicle population in 
a lognormal distribution, slightly broader than the lipid one 
(Figure 3b). A possible explanation of broadening is the 
presence of a minor amount of polypeptides with low or no lipids. 
To assess whether lipids and proteins are colocalized or form 
distinct assemblies we imaged by fluorescence microscopy 
vesicles immobilized into Koliphor® hydrogels. Measurements of 
pixel intensity correlation[28] (Pearsons coefficient = 0.77±0.08 
and Manders coefficients, Mgreen = 0.87±0.03 and Mred = 
0.82±0.02) confirmed that most proteins are embedded in 
liposomes. The presence of a few particles stained in protein 
channel but unstained in lipid channel supports the 
aforementioned hypothesis of a minor fraction of protein-
enriched clusters (Figure 3c). 
Figure 4. a) Schematic representation of the in vivo production of mCherry 
loaded nanovesicles. b) Fluorescence microscopy image of mCherry loaded 
nanovesicles (mCherry in red channel and spDiO in green channel) and c) 
degradation kinetic of free and encapsulated mCherry when exposed to 
proteases. Error bars account for relative error. 
In cellulo loading 
 
Finally, we applied this bacterial expression platform to 
encapsulate soluble proteins (Figure 4). Usual in vitro 
encapsulations of water soluble molecules in the interior of 
liposomes require conditions that may denature proteins, such 
as freeze-drying, the presence of detergents, or interfaces with 
organic solvents.[29–31] For this reason, encapsulation of 
denaturation-prone enzymes or proteins remains challenging. 
The soluble fluorescent protein mCherry was co-expressed with 
ATP-b under the same T7 promotor using a single plasmid 
(Figure S1). Nanovesicles were isolated using the same 
procedure as described above. Fluorescence microscopy 
images of mCherry loaded nanovesicles immobilized in a 
Koliphor® hydrogel showed fluorescent dots dispersed in a dark 
background (Figure 4b, red channel). Colocalization with non-
specific lipophilic spDiO staining revealed that most of the 
nanovesicles are loaded with mCherry (Figure 4b green channel 
and Figure S9). In addition, Western-Blot confirmed the 
presence of mCherry into nanovesicles (Figure S10c). 
Fluorescence spectra of free and nanovesicle entrapped 
mCherry are similar (Figure S11). Altogether, these results point 
to an encapsulation of native soluble mCherry inside the inner 
cavity of the nanovesicles. Protective properties of the lipidic 
nanovesicles against external environment were tested by 
protease digestion experiments. Fluorescence of soluble 
mCherry steadily decreased when non-encapsulated mCherry 
was mixed with proteases. In contrast, the fluorescence of 
mCherry-loaded nanovesicles was preserved under the same 
experimental conditions (Figure 4c). 
 
Conclusions and perspectives 
 In summary, a robust and high yield method is proposed for the 
bioproduction of lipidic nanovesicles decorated with a 
genetically-engineered, custom polypeptide corona that can be 
easily (post)-modified. The density of the polypeptide corona 
largely exceeds (>20 fold) values achieved in artificial 
formulations of proteo-liposomes and enables to reach >95% 
orientation of C-ter end toward the outer solution. This C-ter 
domain remains accessible to post-modifications including in 
vitro sequence-specific cleavage and/or selective thiol-
maleimide addition click conjugation. Furthermore, co-expressed 
soluble proteins can be encapsulated in the interior of the 
nanovesicles, as exemplified with mCherry. 
 
The dense and almost fully oriented array of clickable peptides 
displayed on the top of vesicles could be particularly 
advantageous for applications requiring a high surface density 
functionalization (e.g. introduction of photodynamic therapy 
agents or macromolecules for enhanced shelf-life or vesicle-
inducing fusions).[32,33] As multiple tags can be introduced, they 
could allow multiple-functionalizations; for instance to combine 
specific targeting ligands with bio-repellent molecules.[34] 
Alternatively, proteoliposomes are specially adapted as signal 
amplification systems in biosensors.[35] The present method 
provides a mild in vivo encapsulation of fluorescent proteins and 
possibilities for a dense surface display of fluorophores that 
should be useful for developing probes with high brightness. 
Finally, reconstitution of artificial cell mimics and liposome-based 
sensors is often struggling for co-encapsulating soluble enzymes 
and membrane proteins in capsules.[36–38] The present 
bioproduced lipidic vesicles offers a simple mean to combine all 
these constituents into well-defined assemblies. 
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